|
|
|
|
|
|
26
The 11th Aging Research & Drug Discovery Meeting
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
This year's ARDD will feature leading global pharma and biotech organizations, including Novartis, Insilico Medicine, Eli Lilly, Biogen, Regeneron, Pfizer, Lundbeck, Bioage, Biovie.
Additionally, key stakeholders from the longevity ecosystem, including government representatives and urban planners, will discuss the broader impacts and future directions of longevity science.
The event will be held at the University of Copenhagen and broadcast online. Participate in the desired format by registering here.
|
27
The 11th Aging Research & Drug Discovery Meeting
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
This year's ARDD will feature leading global pharma and biotech organizations, including Novartis, Insilico Medicine, Eli Lilly, Biogen, Regeneron, Pfizer, Lundbeck, Bioage, Biovie.
Additionally, key stakeholders from the longevity ecosystem, including government representatives and urban planners, will discuss the broader impacts and future directions of longevity science.
The event will be held at the University of Copenhagen and broadcast online. Participate in the desired format by registering here.
|
28
The 11th Aging Research & Drug Discovery Meeting
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
This year's ARDD will feature leading global pharma and biotech organizations, including Novartis, Insilico Medicine, Eli Lilly, Biogen, Regeneron, Pfizer, Lundbeck, Bioage, Biovie.
Additionally, key stakeholders from the longevity ecosystem, including government representatives and urban planners, will discuss the broader impacts and future directions of longevity science.
The event will be held at the University of Copenhagen and broadcast online. Participate in the desired format by registering here.
|
29
The 11th Aging Research & Drug Discovery Meeting
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
This year's ARDD will feature leading global pharma and biotech organizations, including Novartis, Insilico Medicine, Eli Lilly, Biogen, Regeneron, Pfizer, Lundbeck, Bioage, Biovie.
Additionally, key stakeholders from the longevity ecosystem, including government representatives and urban planners, will discuss the broader impacts and future directions of longevity science.
The event will be held at the University of Copenhagen and broadcast online. Participate in the desired format by registering here.
|
30
The 11th Aging Research & Drug Discovery Meeting
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 11th Aging Research and Drug Discovery Meeting.
This year's ARDD will feature leading global pharma and biotech organizations, including Novartis, Insilico Medicine, Eli Lilly, Biogen, Regeneron, Pfizer, Lundbeck, Bioage, Biovie.
Additionally, key stakeholders from the longevity ecosystem, including government representatives and urban planners, will discuss the broader impacts and future directions of longevity science.
The event will be held at the University of Copenhagen and broadcast online. Participate in the desired format by registering here.
|
|
|
|